Free Trial

SG Americas Securities LLC Sells 51,064 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Option Care Health logo with Medical background

SG Americas Securities LLC lowered its stake in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 84.6% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 9,292 shares of the company's stock after selling 51,064 shares during the quarter. SG Americas Securities LLC's holdings in Option Care Health were worth $291,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently bought and sold shares of OPCH. Park Place Capital Corp lifted its holdings in shares of Option Care Health by 48.4% in the first quarter. Park Place Capital Corp now owns 1,140 shares of the company's stock valued at $38,000 after purchasing an additional 372 shares in the last quarter. Blue Trust Inc. raised its position in Option Care Health by 14.8% during the second quarter. Blue Trust Inc. now owns 2,931 shares of the company's stock valued at $81,000 after buying an additional 377 shares during the period. SageView Advisory Group LLC purchased a new stake in Option Care Health in the 1st quarter worth about $85,000. Headlands Technologies LLC acquired a new stake in Option Care Health during the 2nd quarter worth about $137,000. Finally, MeadowBrook Investment Advisors LLC grew its stake in Option Care Health by 36.1% during the 2nd quarter. MeadowBrook Investment Advisors LLC now owns 6,610 shares of the company's stock valued at $183,000 after acquiring an additional 1,755 shares in the last quarter. Hedge funds and other institutional investors own 98.05% of the company's stock.

Insider Activity at Option Care Health

In other news, Director Elizabeth Quadros Betten sold 47,531 shares of the company's stock in a transaction dated Wednesday, August 21st. The stock was sold at an average price of $31.09, for a total transaction of $1,477,738.79. Following the completion of the sale, the director now owns 21,339 shares in the company, valued at approximately $663,429.51. This represents a 0.00 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. In related news, CFO Michael H. Shapiro sold 23,217 shares of the business's stock in a transaction dated Thursday, August 22nd. The stock was sold at an average price of $30.95, for a total transaction of $718,566.15. Following the completion of the transaction, the chief financial officer now owns 247,317 shares of the company's stock, valued at approximately $7,654,461.15. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Elizabeth Quadros Betten sold 47,531 shares of the stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $31.09, for a total value of $1,477,738.79. Following the sale, the director now owns 21,339 shares of the company's stock, valued at approximately $663,429.51. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. 0.64% of the stock is owned by company insiders.

Analyst Ratings Changes

OPCH has been the subject of a number of research analyst reports. Barrington Research increased their price target on shares of Option Care Health from $38.00 to $40.00 and gave the stock an "outperform" rating in a research report on Thursday, August 1st. JMP Securities lifted their target price on shares of Option Care Health from $36.00 to $37.00 and gave the company a "market outperform" rating in a research note on Monday, September 30th.

View Our Latest Research Report on OPCH

Option Care Health Stock Down 3.6 %

Shares of OPCH traded down $1.13 during midday trading on Monday, reaching $30.51. 1,475,263 shares of the stock were exchanged, compared to its average volume of 1,406,684. The company has a market cap of $5.30 billion, a price-to-earnings ratio of 20.07, a P/E/G ratio of 2.21 and a beta of 1.29. The company has a quick ratio of 1.36, a current ratio of 1.76 and a debt-to-equity ratio of 0.78. Option Care Health, Inc. has a 12-month low of $26.11 and a 12-month high of $34.63. The firm has a 50 day simple moving average of $31.09 and a 200-day simple moving average of $30.12.

Option Care Health (NASDAQ:OPCH - Get Free Report) last issued its quarterly earnings data on Wednesday, July 31st. The company reported $0.30 earnings per share for the quarter, beating the consensus estimate of $0.27 by $0.03. The firm had revenue of $1.23 billion for the quarter, compared to analyst estimates of $1.17 billion. Option Care Health had a net margin of 4.60% and a return on equity of 14.82%. The company's revenue for the quarter was up 14.8% on a year-over-year basis. During the same quarter last year, the firm earned $0.63 earnings per share. Research analysts forecast that Option Care Health, Inc. will post 1.22 EPS for the current year.

About Option Care Health

(Free Report)

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

Read More

Institutional Ownership by Quarter for Option Care Health (NASDAQ:OPCH)

Should you invest $1,000 in Option Care Health right now?

Before you consider Option Care Health, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.

While Option Care Health currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Why Whitestone REIT is Outperforming in 2024: 35% Growth & Monthly Dividends
Why SoundHound Stock Dip Could Mean Big Gains for 2025 Investors
Nintendo Stock: Buy Before the 2025 Switch Platform Hits!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines